CVS Caremark Corporation (CVS) reported on Wednesday that it has agreed to acquire infusion services and nutrition business Coram LLC for $2.1 billion.
CVS will purchase Coram from Apria Healthcare Group Inc in a deal that will likely close in the first quarter of 2014. CVS said that this acquisition is expected to add $1.4 billion to revenue in the first year and 3 to 5 cents per share in 2015. This purchase is in-line with the company strategy of focusing on core businesses that will drive growth.
Jon Roberts, President of CVS Caremark Pharmacy Services said in a statement: “Bringing together CVS Caremark’s unique range of specialty pharmacy services with Coram’s infusion capabilities will expand our competitive offerings in the specialty arena. Infusion will be a valuable component of our broad specialty pharmacy offering going forward. Our comprehensive services will enable us to streamline care management for patients as well as their physicians, leading to better health outcomes while avoiding unnecessary costs.”
CVS Caremark shares were mostly flat during pre-market trading Wednesday. The stock is up 27% YTD.